PuraPharm Corporation Limited (1498.HK)
HKD 0.47
(-2.08%)
HKD 0.47
(-2.08%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 175.59 Million HKD | -7.97% |
| 2022 | 190.81 Million HKD | -4.5% |
| 2021 | 199.79 Million HKD | 5.07% |
| 2020 | 190.15 Million HKD | -9.87% |
| 2019 | 210.96 Million HKD | -18.7% |
| 2018 | 259.49 Million HKD | -13.71% |
| 2017 | 300.72 Million HKD | 80.0% |
| 2016 | 167.06 Million HKD | 54.71% |
| 2015 | 107.98 Million HKD | 20.13% |
| 2014 | 89.89 Million HKD | 37.84% |
| 2013 | 65.21 Million HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 146.7 Million HKD | -16.45% |
| 2023 Q2 | 203.95 Million HKD | 6.89% |
| 2023 FY | 175.59 Million HKD | -7.97% |
| 2023 Q4 | 175.59 Million HKD | -13.9% |
| 2022 FY | 190.81 Million HKD | -4.5% |
| 2022 Q4 | 190.81 Million HKD | -9.37% |
| 2022 Q2 | 210.53 Million HKD | 5.37% |
| 2021 FY | 199.79 Million HKD | 5.07% |
| 2021 Q4 | 199.79 Million HKD | 15.25% |
| 2021 Q2 | 173.36 Million HKD | -8.83% |
| 2020 Q4 | 190.15 Million HKD | -11.37% |
| 2020 Q2 | 214.54 Million HKD | 1.7% |
| 2020 FY | 190.15 Million HKD | -9.87% |
| 2019 FY | 210.96 Million HKD | -18.7% |
| 2019 Q4 | 210.96 Million HKD | -10.74% |
| 2019 Q2 | 236.35 Million HKD | -8.92% |
| 2018 Q4 | 259.49 Million HKD | -6.51% |
| 2018 FY | 259.49 Million HKD | -13.71% |
| 2018 Q2 | 277.57 Million HKD | -7.7% |
| 2017 FY | 300.72 Million HKD | 80.0% |
| 2017 Q4 | 300.72 Million HKD | 25.27% |
| 2017 Q2 | 240.05 Million HKD | 43.69% |
| 2016 Q4 | 167.06 Million HKD | 31.49% |
| 2016 FY | 167.06 Million HKD | 54.71% |
| 2016 Q2 | 127.05 Million HKD | 17.65% |
| 2015 FY | 107.98 Million HKD | 20.13% |
| 2015 Q4 | 107.98 Million HKD | 2.16% |
| 2015 Q2 | 105.7 Million HKD | 17.59% |
| 2014 FY | 89.89 Million HKD | 37.84% |
| 2014 Q4 | 89.89 Million HKD | 0.0% |
| 2013 FY | 65.21 Million HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -1339.674% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 87.355% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -2317.027% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 43.006% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 59.332% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 41.096% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -179.515% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -78.696% |
| SSY Group Limited | 1.08 Billion HKD | 83.835% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -91.731% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 44.756% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.5% |